Transcept Pharmaceuticals Inc - TSPT - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Transcept Pharmaceuticals Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
TSPT	Nasdaq	8731	http://www.transcept.com	3.10 +0.02
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Transcept Pharmaceuticals Inc Nasdaq stocks posting largest percentage decreases - May 24th, 2013 4:04 pm TRANSCEPT PHARMACEUTICALS INC Financials - May 17th, 2013 11:04 am Locust Walk Partners Announces Appointment of Chris Ehrlich, Biotechnology Industry and Venture Capital Veteran, as Managing Director - May 14th, 2013 7:25 am TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Other Events - May 13th, 2013 7:41 am Transcept Pharmaceuticals downgraded to Hold from Buy at MLV Equity - May 10th, 2013 5:25 am Transcept Pharma downgraded by MLV & Co - May 9th, 2013 10:18 pm Transcept: Throwing In The Towel On Intermezzo - May 9th, 2013 8:46 am TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities - May 9th, 2013 7:43 am Transcept downgraded to Market Perform from Outperform at JMP Securities - May 9th, 2013 6:00 am Transcept downgraded to Market Perform from Outperform at Leerink - May 9th, 2013 3:36 am Transcept Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript - May 8th, 2013 4:10 pm Transcept Pharmaceuticals Reports First Quarter 2013 Financial Results - May 8th, 2013 11:25 am Narrower-than-Expected Loss at Seattle Genetics - May 8th, 2013 8:00 am TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - May 8th, 2013 7:07 am Impax Beats Earnings Estimate - May 2nd, 2013 6:50 am Transcept Pharmaceuticals to Report First Quarter 2013 Financial Results and Host Conference Call on May 8, 2013 - May 1st, 2013 2:15 pm AMAG Narrows Loss; Maintains View - Apr 24th, 2013 1:45 pm Merck - BMY in HCV Deal - Apr 23rd, 2013 3:40 pm Merck In-Licenses from Xenon - Apr 22nd, 2013 3:20 pm Sanofi's Vaccine Gets EU Approval - Apr 22nd, 2013 9:40 am View All Current Headlines >>